# Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics)

> **NCT00690612** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 35 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** candesartan cilexetil

## Key facts

- **NCT ID:** NCT00690612
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2011-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00690612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00690612, "Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00690612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*